NCT05091047

Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain

A Pilot Evaluation of the Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: Erchonia Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to see if applying red and violet low-level laser light can help to reduce foot pain associated with diabetic peripheral neuropathy,

Detailed description

The purpose of this study is to determine whether low level laser therapy is effective in the reduction of foot pain associated with diabetic peripheral neuropathy, when used at home by non-medical professionals.

Conditions

• Neuropathy

Interventions

Type	Name	Description
DEVICE	Erchonia EVRL	42 procedure administrations with the Erchonia® EVRL™ administered by the subject at home: Twice daily procedure administrations for 3 weeks.

Timeline

• Start date: 2021-06-16
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2021-10-25
• Last updated: 2022-06-06
• Results posted: 2022-06-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study